NCT07530484

Brief Summary

This study aims to evaluate the effect of sling insertion angle on surgical outcomes and quality of life in women with stress urinary incontinence (SUI) undergoing single-incision midurethral sling surgery. Women diagnosed with urodynamic stress urinary incontinence who underwent surgery using a single-incision sling system were included. Patients were categorized into two groups based on sling insertion angle: an acute-angle group (\<45°, resembling a retropubic trajectory) and a standard-angle group (approximately 45°, toward the obturator foramen). The primary outcome was objective cure at 6 months, defined as a negative cough stress test without the need for additional anti-incontinence treatment. Secondary outcomes included objective cure at 1 and 3 months, postoperative voiding difficulty, persistent SUI symptoms, and quality of life assessed using the Incontinence Quality of Life (I-QOL) questionnaire. This study provides clinical evidence on whether sling insertion angle influences early and mid-term outcomes following single-incision midurethral sling surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
184

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2019

Completed
6.4 years until next milestone

First Submitted

Initial submission to the registry

April 8, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 15, 2026

Completed
Last Updated

April 15, 2026

Status Verified

April 1, 2026

Enrollment Period

2.1 years

First QC Date

April 8, 2026

Last Update Submit

April 8, 2026

Conditions

Keywords

Single-incision midurethral slingSling insertion angleStress urinary incontinenceI-QOLObjective cureVoiding dysfunction

Outcome Measures

Primary Outcomes (1)

  • Objective cure rate at 6 months

    Objective cure is defined as a negative cough stress test and no requirement for additional anti-incontinence treatment at 6 months after surgery.

    6 months after surgery

Secondary Outcomes (4)

  • Objective cure rate at 1 and 3 months

    1 month and 3 months

  • Postoperative voiding difficulty

    Within 6 months after surgery

  • Persistent stress urinary incontinence symptoms

    Up to 6 months

  • Quality of life measured by I-QOL score

    6 months

Study Arms (2)

Acute-angle sling group (<45°)

Participants undergoing single-incision midurethral sling surgery with a sling insertion angle of less than 45 degrees, corresponding to a retropubic, TVT-like trajectory. This approach is hypothesized to provide earlier urethral support and improved early continence outcomes.

Standard-angle sling group (≈45°)

Participants undergoing single-incision midurethral sling surgery with a standard sling insertion angle of approximately 45 degrees toward the obturator foramen. This represents the conventional transobturator-oriented trajectory used in routine clinical practice.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult female patients diagnosed with urodynamic stress urinary incontinence who underwent single-incision midurethral sling surgery at a tertiary medical center. All procedures were performed by a single experienced surgeon, and patients had available follow-up data for at least 6 months.

You may qualify if:

  • Female patients aged 18 years or older
  • Diagnosis of urodynamic stress urinary incontinence (SUI)
  • Preoperative 1-hour pad test \>10 g
  • Undergoing single-incision midurethral sling surgery (ContaSure Needleless system)
  • Availability of complete clinical and follow-up data for at least 6 months

You may not qualify if:

  • Presence of detrusor overactivity on urodynamic study
  • Mixed urinary incontinence with predominant urge symptoms
  • Voiding dysfunction
  • History of prior pelvic or anti-incontinence surgery
  • Neurological disorders affecting lower urinary tract function
  • Pelvic organ prolapse stage ≥ III (POP-Q classification)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shin Kong Wu Ho-Su Memorial Hospital

Taipei, Taiwan, 111, Taiwan

Location

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital

Study Record Dates

First Submitted

April 8, 2026

First Posted

April 15, 2026

Study Start

October 1, 2017

Primary Completion

October 31, 2019

Study Completion

October 31, 2019

Last Updated

April 15, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to patient privacy concerns and institutional restrictions. The data contain potentially identifiable clinical information, and sharing is not permitted under the approval of the Institutional Review Board. De-identified data may be available from the corresponding author upon reasonable request and with appropriate institutional approvals.

Locations